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Conclusions: Dose response for local control based on D90 of HR CTV 
is significant in a multicenter setting. Overall local control can be 
obtained in 95% of the patients when D90 of HR CTV>92 Gy. The 
analysis further points to FIGO stage, tumour width at diagnosis, 
volume of HR CTV and histology as important determinants for TCD90 
and TCD95.  
 
 POSTER DISCUSSION: 7: RTT  
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Purpose/Objective: To determine the current variation in 
radiotherapy practice for the treatment of cervical cancer across the 
United Kingdom (UK) with the aim of developing a comprehensive 
radiotherapy quality assurance (QA) programme for both external 
beam radiotherapy (EBRT) and brachytherapy within the context of 
the INTERLACE trial: a phase III trial of weekly induction 
chemotherapy and chemoradiation versus standard chemoradiation. 
The data will also be used to help determine the need for a national 
brachytherapy dosimetry audit. 
Materials and Methods: A pre-trial questionnaire was circulated to 31 
radiotherapy centres that had expressed interest in participating in 
INTERLACE. In addition to external beam radiotherapy (EBRT) details, 
in depth information on brachytherapy technique and QA was 
collected. 
Results: To date, 22 questionnaires have been completed and 
evaluated. Local practice was seen to vary significantly between 
centres with particular variation in brachytherapy techniques. For 
EBRT, all but 2 centres localise using CT and MRI modalities, only 6 of 
these also utilise PET imaging. Seven out of 22 centres use 3D virtual 
simulation (Vsim) techniques for EBRT planning. With respect to total 
EQD2 dose, 9 out of 22 centres did not achieve the proposed minimum 
dose requirement for the trial of 78 Gy, with values ranging from 68.3 
to 83.9 Gy. The intended trial requirement for the overall treatment 
time of ≤ 50 days was also not met by 7 of the 22 centres. Out of 21 
brachytherapy centres, 18 use 3D imaging for the planning of all 
fractions. Twelve of these optimise their plans for each individual 
patient; 6 to the target volume and 6 to OAR volumes or ICRU points, 
while the remaining 9 use standard plans. Six out of 21 centres have 
not participated in any brachytherapy dosimetry audit to date. 
Conclusions: The INTERLACE pre-trial questionnaire has revealed a 
wide variation in dose fractionation and treatment techniques being 
used in centres across the UK. Following our results new minimum 
standards for centres wishing to participate in the INTERLACE trial 
have been set. Now Vsim techniques for EBRT planning will not be 
permitted from UK centres. This will therefore require an advance in 
technique to 3D conformal planning for some centres. Several centres 
will be required to increase their total EQD2 dose for trial patients. 
The overall treatment time has now been amended to up to 56 days. 
Finally our results have highlighted the need for a national 
brachytherapy dosimetry audit which is now currently under 
development. 
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Background: Our instituition has been treating brain metastasis using 
LINAC based stereotactic radiosurgery with micromultileaf collimator 
(Brainlab M3) since 2008. Patients are immobilised using Brainlab 
fixation and treated with static fixed fields (6MV photon). In June 
2012 a TrueBeam STX (Varian Medical Systems) was installed. Patients 
with localised CNS lesions are now treated with 10MV flattening filter 
free (FFF) volumetric modulated arc therapy VMAT.  
Purpose: This study evaluated the impact of the new technique by 
comparing beam on time (BOT), time in room (TIR), and clinical dose 
rate (CDR) with the previous technique.  
Materials and Methods: BOT (minutes:seconds) is the aggregate 
‘‘beam-on’’ time for all fields or arcs in a given plan. TIR 
(minutes:seconds) is measured from the first alignment image to last 
beam off, inclusive of all pre-treatment imaging studies and/or shifts. 
Static field patients had MV imaging only. VMAT patients had kV 
imaging and pre-treatment cone beam CT (CBCT). Clinical dose rate 
(CDR) (MU/min) is the number of monitor units (MU) divided by the 
BOT. Treatment records were reviewed for 20 patients on Varian 
Eclipse and Offline review. The median planning target volume was 
5.41cm3 (min 0.98cm3 max 18.88cm3). 18 patients had single 
metastasis, 2 patients had 2 mets.10 patients were treated with 6MV 
static fields (between 4 and 6 fields) and 10 patients with 10MV FFF 
(All 10 Patients had 2 arcs). 11 patients were treated with 20Gy, 7: 
18Gy and 2: 15Gy.  
Results 
 6X STATIC VMAT 
BOT 5:85  
Range 4:55 – 6:6 
2:60 
Range 2:01 – 3.9 
TIR 34:17  
Range 20:42-58:13 
17:12  
Range 12:42 - 28:28
MU 2726 
Range 2119-3168 
MU 6216.5  
Range 4472-9340 
CDR 600 MU/min 2385.5 MU/min 
 
Conclusions: The implementation of VMAT FFF has dramatically 
reduced the TIR. The shorter BOT reduces the likelihood of 
intrafraction motion although this cannot be verified as no post 
treatment CBCT was performed. It is envisaged that VMAT FFF 
treatment times will be reduced further as Radiographer competency 
and skill increases. This is essential in busy RT departments where 
treatment slots are at a premium.  
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Purpose/Objective: This study examined the use of Systematic 
Common Terminology Criteria for Adverse Events v. 3.0 (CTC) 
registration to enable consistent patient care and prevention of acute 
side-effects from radiotherapy (RT). The goal was to enhance the 
ability of the radiation therapist nurses (RTN) to evaluate and act on 
acute side-effects. Hence we investigated whether performing CTC 
registration on specific weekdays compared to doing the registration 
on specific treatment fractions improved the quality of patient care as 
well as the toxicity data collection. Furthermore, we studied whether 
CTC registration combined with prior delegated medical actions and 
supplementary nurse prescribing reduced the need for physician 
consultations and interventions. 
Materials and Methods: We randomly selected 20 patients treated 
with RT for rectal cancer during October 2011. At that time point, 
CTC registration was done on every fifth day of the patient's 
treatment course. We evaluated the relative number of planned CTC 
registrations actually performed and all medical interventions. This 
was compared to similar data collected for 20 randomly selected 
rectal cancer patients treated during October 2012, where CTC 
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registration was carried out on a predefined day of the week. 
Proportions were compared using Fisher's Exact test.  
Results: For patients evaluated on a fixed treatment fraction (October 
2011), 58 CTC registrations out of 134 (0.43, 95% CI: 0.39–0.48) 
planned registrations were recorded. For patients evaluated on a 
predefined weekday (October 2012), 83 CTC registrations were 
performed out of 108 possible (0.77, 0.72–0.81). The absolute 
difference in the proportions of registrations performed was 0.34 (95% 
CI: 0.21–0.45, p<0.0001). Of the 20 patients treated in October 2011, 
19 (0.95, 95% CI: 0.84–0.99) received medical treatment of their acute 
side effects administered by a RTN, by the use of prior delegated 
medical interventions (i.e. no physician involvement). In October 
2012, only 12 of the 20 patients (0.60, 0.46–0.72) received medical 
treatment. This corresponds to an absolute decrease in medical 
treatment of acute side-effects by 0.35 (0.10–0.58, p=0.02). 
Conclusions: We found an increased number of planned registrations 
performed as well as a decrease in the number of patients in need of 
medical treatment of acute side effects. This is believed to reflect 
that improved CTC registration results in more effective early nursing 
interventions from the RTN. The pre-defined levels in the CTC-system 
and the prior delegated medical intervention options allow for quick 
and independent response to acute RT toxicity by the RTN. As an 
added benefit, systematic CTC registrations will provide additional 
and improved scientific data on patients' tolerance to RT. 
As this is a retrospective study comparing two patient cohorts, there 
may be an effect of simply introducing a new procedure on the 
compliance with planned toxicity scoring. However, the decrease in 
medical interventions following an increased focus on consistent 
toxicity scoring is nevertheless of interest. 
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Purpose/Objective: Severe acute radiation-induced skin reactions 
occur in a significant proportion of women who receive radiation 
therapy for breast cancer. We previously showed that Mepilex Lite 
dressings decreased the severity of erythema. Here we report their 
effect on the full range of skin reactions in 74 breast cancer patients 
post-mastectomy.  
Materials and Methods: A total of 80 women were recruited from four 
hospitals in New Zealand with 74 women contributing a full data set 
for analysis. The first skin area on the chest wall to develop erythema 
was randomly divided into two similar halves; one half was treated 
with Mepilex Lite dressings, the other half with aqueous cream. Skin 
reactions were assessed using the Radiation-Induced Skin Reaction 
Assessment Scale (RISRAS).  
Results: Compared with aqueous cream, Mepilex Lite dressings did not 
significantly reduce the incidence of moist desquamation but did 
reduce the overall severity of skin reactions by 41%, the average moist 
desquamation score by 49% and the sum of the moist desquamation 
time for all patches by 28% (see table below). Most patients preferred 
the dressings, found them easy to use and very comfortable to wear. 
 
Table1: Key trial results 
Measures Aqueous Cream Mepilex 
p values 
RISRAS (combined) 3.02 ± 0.29 1.77 ± 0.12 <0.001 (t-test) 
RISRAS (moist 
desquamation) 0.37 0.18 
0.043 (t-test) 
Incidence of moist 
desquamation 19% 15%  
0.55 
(binomial) 
Time to moist 
desquamation 49.9 ± 3.3 days 40.3 ± 2.7 days 
0.93 (PROC
MIXED)  
Time to healing 12.5 ± 1.5 days 11.4 ± 1.7 days 
0.66 (PROC
MIXED) 
Total moist 
desquamation time 25 weeks 18 weeks 
NA 
 
Conclusions: Mepilex Lite dressings reduce all aspects of radiation-
induced skin reactions. 
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Purpose/Objective: Radiation induced toxicity is a common adverse 
side effect of radiation therapy. Radiotherapy may cause varying 
degrees of physical skin reactions, and contribute to a patient’s 
overall quality of life. A recent Society and College of Radiographers 
(SCoR) survey of skincare practice in the UK highlighted a lack of 
convincing evidence to support skincare advice for radiotherapy 
patients in relation to prevention and management of skin reactions.  
The purpose of this research study was to investigate current skin care 
practice for radiotherapy patients across Europe and the United States 
of America (USA). The published literature was used as a guide to 
assess the appropriateness of current clinical guidelines. 
Materials and Methods: A link to an online survey, using 
'SurveyMonkey' was emailed to departments (N=737) across Europe and 
the USA. This survey was based on a questionnaire from the SCoR 
study, which was adapted, with permission, for a wider radiotherapy 
community. Each radiotherapy department manager was asked to 
select one radiation therapist per department to complete the survey. 
Data was collected and analysed using SPSS version 20.0 and Microsoft 
excel. 
Results: One hundred and eighty one departments responded, giving a 
response rate of 25%. Results of the survey highlight disparities 
between clinical practice and research findings. Information provided 
to patients on how to manage their skin during radiotherapy is often 
inconsistent and outdated. A plethora of agents is used in a non-
standardised manner.  
Based on the results of this study, and current literature, an evidence-
based skincare information leaflet for patients was devised.  
Conclusions: A large variation was seen between departments with 
regard to current skincare practice. It highlights the need for further 
studies to be carried out in order to develop an evidence base for the 
skincare advice given to radiotherapy patients, and to eliminate non-
standardised practice.  
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Purpose/Objective: It is of importance to take the shoulder position 
into account when planning radiotherapy for head and neck cancer 
patients. The purpose of this study is: 1) to evaluate how 
interfractional variations of the shoulder position affect the dose 
distribution for RA compared to IMRT and 2) to develop an 
optimisation method for RA treatment planning in order to increase 
robustness to shoulder position variations.  
Materials and Methods: One IMRT and two RA treatment plans (TPs) 
were made for a number of patients. The two RA TPs (RA anisotropic 
and RA isotropic) were prepared with and without taking the shoulders 
into account in the optimisation, respectively. The former was done 
with different methods e.g. using optimisation objectives on the 
delineated shoulders, by using avoiding sectors, or a combination of 
the two methods. The robustness of the different techniques and the 
different methods was investigated by simulating different shoulder 
positions in the treatment planning system. The body outline was 
edited to simulate when shoulders 'falls down' and 'moves up' and the 
original TPs were applied on the corresponding structure sets. 
Changes in dose distribution and dosimetric parameters e.g. CTV 
volume covered by 95% of the prescribed dose (V95(CTV)), dose max 
to ORs etc. was used to investigate the robustness of the TPs for the 
simulated shoulder positions. For relevant cases the body outlines 
from CBCT-scans acquired during the course of treatment, were 
transferred to the original CT set, in order to investigate how the 
shoulder position affect the dose in clinical situations.  
Results: The figure illustrates simulated cases where the shoulders 
'move up' 1 cm and 1.5 cm and how this affects the dose distribution 
for the IMRT, RA isotropic and RA anisotropic TPs, respectively. The 
IMRT plan was created with fixed beam angle geometry that takes the 
shoulders into account. As expected the IMRT was robust for 
interfractional variation of the shoulder position e.g. V95(CTV)=100%, 
for all simulated IMRT cases. The RA TPs were robust (e.g. 
V95(CTV)=100%) for small movements (1cm or less). If the shoulder 
 
 
